Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Protocol of a Nationwide Observational Study among Patients with Nontuberculous Mycobacterium Pulmonary Disease in South Korea (NTM-KOREA).

Kwak N, Choi H, Jeon D, Jhun BW, Jo KW, Kang YA, Kwon YS, Lee M, Mok J, Shim TS, Shin HJ, Whang J, Yim JJ.

Tuberc Respir Dis (Seoul). 2020 Mar 10. doi: 10.4046/trd.2019.0077. [Epub ahead of print]

2.

miRNA Expression Profiles and Potential as Biomarkers in Nontuberculous Mycobacterial Pulmonary Disease.

Han SA, Jhun BW, Kim SY, Moon SM, Yang B, Kwon OJ, Daley CL, Shin SJ, Koh WJ.

Sci Rep. 2020 Feb 21;10(1):3178. doi: 10.1038/s41598-020-60132-0.

3.

Prognostic value of SUVmax on 18F-fluorodeoxyglucose PET/CT scan in patients with malignant pleural mesothelioma.

Lim JH, Choi JY, Im Y, Yoo H, Jhun BW, Jeong BH, Park HY, Lee K, Kim H, Kwon OJ, Han J, Ahn MJ, Kim J, Um SW.

PLoS One. 2020 Feb 18;15(2):e0229299. doi: 10.1371/journal.pone.0229299. eCollection 2020.

4.

Development of tuberculosis in cancer patients receiving immune checkpoint inhibitors.

Im Y, Lee J, Kim SJ, Koh WJ, Jhun BW, Lee SH.

Respir Med. 2020 Jan;161:105853. doi: 10.1016/j.rmed.2019.105853. Epub 2019 Dec 14.

PMID:
32056727
5.

Treatment of Isoniazid-Resistant Pulmonary Tuberculosis.

Jhun BW, Koh WJ.

Tuberc Respir Dis (Seoul). 2020 Jan;83(1):20-30. doi: 10.4046/trd.2019.0065. Review.

6.

The utility of endosonography for mediastinal staging of non-small cell lung cancer in patients with radiological N0 disease.

Shin SH, Jeong BH, Jhun BW, Yoo H, Lee K, Kim H, Kwon OJ, Han J, Kim J, Lee KS, Um SW.

Lung Cancer. 2020 Jan;139:151-156. doi: 10.1016/j.lungcan.2019.11.021. Epub 2019 Nov 26.

PMID:
31805443
7.

Clinical Characteristics and Outcomes of Surgically Resected Solitary Pulmonary Nodules Due to Nontuberculous Mycobacterial Infections.

Choi Y, Jhun BW, Kim J, Huh HJ, Lee NY.

J Clin Med. 2019 Nov 7;8(11). pii: E1898. doi: 10.3390/jcm8111898.

8.

Diagnostic Performance of the GENEDIA MTB/NTM Detection Kit for Detecting Mycobacterium tuberculosis and Nontuberculous Mycobacteria With Sputum Specimens.

Shin S, Yoo IY, Shim HJ, Kang OK, Jhun BW, Koh WJ, Huh HJ, Lee NY.

Ann Lab Med. 2020 Mar;40(2):169-173. doi: 10.3343/alm.2020.40.2.169.

9.

Early cidofovir administration might be associated with a lower probability of respiratory failure in treating human adenovirus pneumonia: a retrospective cohort study.

Ko JH, Lim JU, Choi JY, Oh HS, Yoo H, Jhun BW, Huh K, Peck KR.

Clin Microbiol Infect. 2019 Oct 21. pii: S1198-743X(19)30545-2. doi: 10.1016/j.cmi.2019.10.012. [Epub ahead of print]

PMID:
31648000
10.

Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: a 15-year follow-up study.

Jhun BW, Moon SM, Jeon K, Kwon OJ, Yoo H, Carriere KC, Huh HJ, Lee NY, Shin SJ, Daley CL, Koh WJ.

Eur Respir J. 2020 Jan 2;55(1). pii: 1900798. doi: 10.1183/13993003.00798-2019. Print 2020 Jan.

PMID:
31619468
11.

Intermittent Treatment with Azithromycin and Ethambutol for Noncavitary Mycobacterium avium Complex Pulmonary Disease.

Moon SM, Yoo IY, Huh HJ, Lee NY, Jhun BW.

Antimicrob Agents Chemother. 2019 Dec 20;64(1). pii: e01787-19. doi: 10.1128/AAC.01787-19. Print 2019 Dec 20.

PMID:
31611366
12.

Computed tomographic findings of macrolide-resistant Mycobacterium massiliense pulmonary disease and changes after antibiotic treatment.

Yoon HJ, Chung MJ, Koh WJ, Jhun BW, Moon SM.

Medicine (Baltimore). 2019 Sep;98(36):e16826. doi: 10.1097/MD.0000000000016826.

13.

Final treatment outcomes of delamanid-containing regimens in patients with MDR-/XDR-TB in South Korea.

Mok J, Kang H, Koh WJ, Jhun BW, Yim JJ, Kwak N, Lee T, Kang B, Jeon D.

Eur Respir J. 2019 Nov 7;54(5). pii: 1900811. doi: 10.1183/13993003.00811-2019. Print 2019 Nov. No abstract available.

PMID:
31285308
14.

First Isolation of Mycobacterium virginiense From a Human Pulmonary Specimen.

Jung J, Yoo IY, Jhun BW, Koh WJ, Lee NY, Huh HJ.

Ann Lab Med. 2019 Nov;39(6):596-598. doi: 10.3343/alm.2019.39.6.596. No abstract available.

15.

In Vitro Activity of Bedaquiline and Delamanid against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates.

Kim DH, Jhun BW, Moon SM, Kim SY, Jeon K, Kwon OJ, Huh HJ, Lee NY, Shin SJ, Daley CL, Koh WJ.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00665-19. doi: 10.1128/AAC.00665-19. Print 2019 Aug.

16.

GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.

Huh HJ, Kim SY, Shim HJ, Kim DH, Yoo IY, Kang OK, Ki CS, Shin SY, Jhun BW, Shin SJ, Daley CL, Koh WJ, Lee NY.

J Clin Microbiol. 2019 Jul 26;57(8). pii: e00516-19. doi: 10.1128/JCM.00516-19. Print 2019 Aug.

17.

Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease.

Moon SM, Jhun BW, Baek SY, Kim S, Jeon K, Ko RE, Shin SH, Lee H, Kwon OJ, Huh HJ, Ki CS, Lee NY, Chung MJ, Lee KS, Shin SJ, Daley CL, Koh WJ.

Respir Med. 2019 May;151:1-7. doi: 10.1016/j.rmed.2019.03.014. Epub 2019 Mar 26.

PMID:
31047103
18.

Species Distribution and Macrolide Susceptibility of Mycobacterium fortuitum Complex Clinical Isolates.

Kim SY, Moon SM, Jhun BW, Kwon OJ, Huh HJ, Lee NY, Lee SH, Shin SJ, Kasperbauer SH, Huitt GA, Daley CL, Koh WJ.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e02331-18. doi: 10.1128/AAC.02331-18. Print 2019 Jun.

19.

M ycobacterium abscessus pulmonary disease: individual patient data meta-analysis.

Kwak N, Dalcolmo MP, Daley CL, Eather G, Gayoso R, Hasegawa N, Jhun BW, Koh WJ, Namkoong H, Park J, Thomson R, van Ingen J, Zweijpfenning SMH, Yim JJ.

Eur Respir J. 2019 Jul 11;54(1). pii: 1801991. doi: 10.1183/13993003.01991-2018. Print 2019 Jul.

PMID:
30880280
20.

Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 2. Idiopathic Pulmonary Fibrosis.

Lee SH, Yeo Y, Kim TH, Lee HL, Lee JH, Park YB, Park JS, Kim YH, Song JW, Jhun BW, Kim HJ, Park J, Uh ST, Kim YW, Kim DS, Park MS; Korean Interstitial Lung Diseases Study Group.

Tuberc Respir Dis (Seoul). 2019 Apr;82(2):102-117. doi: 10.4046/trd.2018.0091. Epub 2019 Feb 28. Review.

21.

Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease.

Moon SM, Choe J, Jhun BW, Jeon K, Kwon OJ, Huh HJ, Lee NY, Daley CL, Koh WJ.

Respir Med. 2019 Mar;148:37-42. doi: 10.1016/j.rmed.2019.01.012. Epub 2019 Jan 30.

PMID:
30827472
22.

Unresolved issues in treatment outcome definitions for nontuberculous mycobacterial pulmonary disease.

Moon SM, Jhun BW, Daley CL, Koh WJ.

Eur Respir J. 2019 May 23;53(5). pii: 1801636. doi: 10.1183/13993003.01636-2018. Print 2019 May. No abstract available.

PMID:
30819812
23.

Epidemiology of Nontuberculous Mycobacterial Infection, South Korea, 2007-2016.

Lee H, Myung W, Koh WJ, Moon SM, Jhun BW.

Emerg Infect Dis. 2019 Mar;25(3):569-572. doi: 10.3201/eid2503.181597.

24.

Prolonged shedding of type 55 human adenovirus in immunocompetent adults with adenoviral respiratory infections.

Huh K, Kim I, Jung J, Lee JE, Jhun BW, Gu SH, Song DH, Lee EY, Jeong HJ, Yoo H.

Eur J Clin Microbiol Infect Dis. 2019 Apr;38(4):793-800. doi: 10.1007/s10096-019-03471-9. Epub 2019 Jan 29.

PMID:
30693422
25.

Advantages of the AdvanSure MDR-TB GenoBlot assay containing disputed rpoB mutation-specific probes in a routine clinical laboratory setting.

Yoo IY, Huh HJ, Kang OK, Jhun BW, Koh WJ, Lee NY.

Respir Med. 2019 Jan;146:71-75. doi: 10.1016/j.rmed.2018.12.001. Epub 2018 Dec 12.

PMID:
30665521
26.

Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial.

Lee M, Mok J, Kim DK, Shim TS, Koh WJ, Jeon D, Lee T, Lee SH, Kim JS, Park JS, Lee JY, Kim SY, Lee JH, Jo KW, Jhun BW, Kang YA, Ahn JH, Kim CK, Shin S, Song T, Shin SJ, Kim YR, Ahn H, Hahn S, Won HJ, Jang JY, Cho SN, Yim JJ.

Trials. 2019 Jan 16;20(1):57. doi: 10.1186/s13063-018-3053-1.

27.

Genetic mutations in linezolid-resistant Mycobacterium avium complex and Mycobacterium abscessus clinical isolates.

Kim SY, Jhun BW, Moon SM, Jeon K, Kwon OJ, Huh HJ, Lee NY, Shin SJ, Daley CL, Koh WJ.

Diagn Microbiol Infect Dis. 2019 May;94(1):38-40. doi: 10.1016/j.diagmicrobio.2018.10.022. Epub 2018 Nov 30.

PMID:
30581010
28.

18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Assessing Treatment Response of Pulmonary Multidrug-Resistant Tuberculosis.

Choi JY, Jhun BW, Hyun SH, Chung MJ, Koh WJ.

J Clin Med. 2018 Dec 17;7(12). pii: E559. doi: 10.3390/jcm7120559.

29.

Recent advances in molecular diagnostics and understanding mechanisms of drug resistance in nontuberculous mycobacterial diseases.

Huh HJ, Kim SY, Jhun BW, Shin SJ, Koh WJ.

Infect Genet Evol. 2019 Aug;72:169-182. doi: 10.1016/j.meegid.2018.10.003. Epub 2018 Oct 11. Review.

PMID:
30315892
30.

Drug susceptibility patterns of Mycobacterium abscessus and Mycobacterium massiliense isolated from respiratory specimens.

Cho EH, Huh HJ, Song DJ, Lee SH, Kim CK, Shin SY, Ki CS, Jhun BW, Moon SM, Kwon OJ, Koh WJ, Lee NY.

Diagn Microbiol Infect Dis. 2019 Feb;93(2):107-111. doi: 10.1016/j.diagmicrobio.2018.08.008. Epub 2018 Aug 29.

PMID:
30236529
31.

Bronchiectasis and Recurrent Respiratory Infections with a De Novo STAT1 Gain-of-Function Variant: First Case in Korea.

Huh HJ, Jhun BW, Choi SR, Kim YJ, Yun SA, Nham E, Kong T, Ki CS, Koh WJ.

Yonsei Med J. 2018 Oct;59(8):1004-1007. doi: 10.3349/ymj.2018.59.8.1004.

32.

The utility of delta neutrophil index in differentiation of pulmonary tuberculosis from community acquired pneumonia.

Jhun BW, Sim YS, Shin TR, Kim DG.

Sci Rep. 2018 Aug 17;8(1):12343. doi: 10.1038/s41598-018-30967-9.

33.

Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.

Shin SH, Jhun BW, Kim SY, Choe J, Jeon K, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Koh WJ.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e01105-18. doi: 10.1128/AAC.01105-18. Print 2018 Oct.

34.

Comparison of four models predicting the malignancy of pulmonary nodules: A single-center study of Korean adults.

Yang B, Jhun BW, Shin SH, Jeong BH, Um SW, Zo JI, Lee HY, Sohn I, Kim H, Kwon OJ, Lee K.

PLoS One. 2018 Jul 31;13(7):e0201242. doi: 10.1371/journal.pone.0201242. eCollection 2018.

35.

Short- and long-term exposure to ambient air pollution and circulating biomarkers of inflammation in non-smokers: A hospital-based cohort study in South Korea.

Lee H, Myung W, Jeong BH, Choi H, Jhun BW, Kim H.

Environ Int. 2018 Oct;119:264-273. doi: 10.1016/j.envint.2018.06.041. Epub 2018 Jul 5.

PMID:
29982129
36.

Mutations in gyrA and gyrB in Moxifloxacin-Resistant Mycobacterium avium Complex and Mycobacterium abscessus Complex Clinical Isolates.

Kim SY, Jhun BW, Moon SM, Shin SH, Jeon K, Kwon OJ, Yoo IY, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Suh GY, Koh WJ.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e00527-18. doi: 10.1128/AAC.00527-18. Print 2018 Sep.

37.

Development of Macrolide Resistance and Reinfection in Refractory Mycobacterium avium Complex Lung Disease.

Jhun BW, Kim SY, Moon SM, Jeon K, Kwon OJ, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Koh WJ.

Am J Respir Crit Care Med. 2018 Nov 15;198(10):1322-1330. doi: 10.1164/rccm.201802-0321OC.

PMID:
29877739
38.

Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease.

Jhun BW, Yang B, Moon SM, Lee H, Park HY, Jeon K, Kwon OJ, Ahn J, Moon IJ, Shin SJ, Daley CL, Koh WJ.

Antimicrob Agents Chemother. 2018 Jun 26;62(7). pii: e00011-18. doi: 10.1128/AAC.00011-18. Print 2018 Jul.

39.

Changing Epidemiology of Nontuberculous Mycobacterial Lung Diseases in a Tertiary Referral Hospital in Korea between 2001 and 2015.

Ko RE, Moon SM, Ahn S, Jhun BW, Jeon K, Kwon OJ, Huh HJ, Ki CS, Lee NY, Koh WJ.

J Korean Med Sci. 2018 Feb 19;33(8):e65. doi: 10.3346/jkms.2018.33.e65.

40.

Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease.

Choi H, Jhun BW, Kim SY, Kim DH, Lee H, Jeon K, Kwon OJ, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Koh WJ.

Diagn Microbiol Infect Dis. 2018 Apr;90(4):293-295. doi: 10.1016/j.diagmicrobio.2017.12.008. Epub 2017 Dec 16.

PMID:
29329759
41.

Intermittent Antibiotic Therapy for Recurrent Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease.

Jhun BW, Moon SM, Kim SY, Park HY, Jeon K, Kwon OJ, Huh HJ, Ki CS, Lee NY, Chung MJ, Lee KS, Shin SJ, Daley CL, Koh WJ.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e01812-17. doi: 10.1128/AAC.01812-17. Print 2018 Feb.

42.

Risk factors for the development of chronic pulmonary aspergillosis in patients with nontuberculous mycobacterial lung disease.

Jhun BW, Jung WJ, Hwang NY, Park HY, Jeon K, Kang ES, Koh WJ.

PLoS One. 2017 Nov 30;12(11):e0188716. doi: 10.1371/journal.pone.0188716. eCollection 2017.

43.

Different impacts of respiratory symptoms and comorbidities on COPD-specific health-related quality of life by COPD severity.

Lee H, Jhun BW, Cho J, Yoo KH, Lee JH, Kim DK, Lee JD, Jung KS, Lee JY, Park HY.

Int J Chron Obstruct Pulmon Dis. 2017 Nov 13;12:3301-3310. doi: 10.2147/COPD.S145910. eCollection 2017.

44.

Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype.

Koh WJ, Moon SM, Kim SY, Woo MA, Kim S, Jhun BW, Park HY, Jeon K, Huh HJ, Ki CS, Lee NY, Chung MJ, Lee KS, Shin SJ, Daley CL, Kim H, Kwon OJ.

Eur Respir J. 2017 Sep 27;50(3). pii: 1602503. doi: 10.1183/13993003.02503-2016. Print 2017 Sep.

45.

The Utility of Preliminary Patient Evaluation in a Febrile Respiratory Infectious Disease Unit outside the Emergency Department.

Kang JS, Jhun BW, Yoon H, Lim SM, Ko E, Park JH, Hwang SY, Lee SU, Lee TR, Cha WC, Shin TG, Sim MS, Jo IJ.

J Korean Med Sci. 2017 Sep;32(9):1534-1541. doi: 10.3346/jkms.2017.32.9.1534.

46.

Does repeated pleural culture increase the diagnostic yield of Mycobacterium tuberculosis from tuberculous pleural effusion in HIV-negative individuals?

Ko Y, Song J, Lee SY, Moon JW, Mo EK, Park JY, Kim JH, Park S, Hwang YI, Jang SH, Jhun BW, Sim YS, Shin TR, Kim DG, Hong JY, Lee CY, Lee MG, Kim CH, Hyun IG, Park YB.

PLoS One. 2017 Jul 27;12(7):e0181798. doi: 10.1371/journal.pone.0181798. eCollection 2017.

47.

Once-daily dosing of amikacin for treatment of Mycobacterium abscessus lung disease.

Lee H, Sohn YM, Ko JY, Lee SY, Jhun BW, Park HY, Jeon K, Kim DH, Kim SY, Choi JE, Moon IJ, Shin SJ, Park HJ, Koh WJ.

Int J Tuberc Lung Dis. 2017 Jul 1;21(7):818-824. doi: 10.5588/ijtld.16.0791.

PMID:
28633708
48.

Changes in Serum IgA Antibody Levels against the Glycopeptidolipid Core Antigen during Antibiotic Treatment of Mycobacterium avium Complex Lung Disease.

Jhun BW, Kim SY, Park HY, Jeon K, Shin SJ, Koh WJ.

Jpn J Infect Dis. 2017 Sep 25;70(5):582-585. doi: 10.7883/yoken.JJID.2016.523. Epub 2017 Mar 28.

49.

Clofazimine-Containing Regimen for the Treatment of Mycobacterium abscessus Lung Disease.

Yang B, Jhun BW, Moon SM, Lee H, Park HY, Jeon K, Kim DH, Kim SY, Shin SJ, Daley CL, Koh WJ.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e02052-16. doi: 10.1128/AAC.02052-16. Print 2017 Jun.

50.

Effect of a 150 mg dose of rifabutin on serum itraconazole levels in patients with coexisting chronic pulmonary aspergillosis and Mycobacterium avium complex lung disease.

Moon SM, Jhun BW, Lee H, Park HY, Jeon K, Lee SY, Koh WJ.

J Infect Chemother. 2017 Sep;23(9):658-660. doi: 10.1016/j.jiac.2017.02.004. Epub 2017 Mar 8.

PMID:
28284662

Supplemental Content

Support Center